Baker Bros. Advisors’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-106,197
Closed -$1.91M 87
2023
Q3
$1.91M Sell
106,197
-669,727
-86% -$12.8M 0.01% 88
2023
Q2
$15.8M Hold
775,924
0.09% 46
2023
Q1
$16.9M Hold
775,924
0.09% 41
2022
Q4
$24M Buy
775,924
+348,745
+82% +$9.85M 0.14% 36
2022
Q3
$10.9M Hold
427,179
0.07% 60
2022
Q2
$8.67M Hold
427,179
0.05% 66
2022
Q1
$10.6M Hold
427,179
0.06% 66
2021
Q4
$14.8M Hold
427,179
0.07% 67
2021
Q3
$11.6M Hold
427,179
0.05% 75
2021
Q2
$11.1M Hold
427,179
0.05% 74
2021
Q1
$9.21M Hold
427,179
0.04% 79
2020
Q4
$9.18M Sell
427,179
-60,064
-12% -$1.46M 0.03% 77
2020
Q3
$7.19M Sell
487,243
-26,434
-5% -$477K 0.03% 72
2020
Q2
$11.5M Buy
513,677
+279,085
+119% +$5.1M 0.05% 55
2020
Q1
$3.31M Buy
234,592
+121,506
+107% +$1.84M 0.02% 75
2019
Q4
$1.84M Hold
113,086
0.01% 86
2019
Q3
$3.96M Hold
113,086
0.03% 68
2019
Q2
$6.38M Hold
113,086
0.04% 59
2019
Q1
$8.26M Hold
113,086
0.05% 51
2018
Q4
$7.21M Hold
113,086
0.06% 51
2018
Q3
$11.3M Buy
113,086
+40,000
+55% +$3.32M 0.07% 51
2018
Q2
$5.19M Sell
73,086
-18,000
-20% -$1.51M 0.04% 73
2018
Q1
$9.48M Sell
91,086
-90,300
-50% -$10.2M 0.08% 60
2017
Q4
$18.3M Buy
181,386
+70,000
+63% +$5.15M 0.16% 47
2017
Q3
$3.89M Sell
111,386
-5,825
-5% -$157K 0.03% 83
2017
Q2
$2.81M Sell
117,211
-32,789
-22% -$824K 0.02% 76
2017
Q1
$4.16M Buy
+150,000
New +$3.49M 0.03% 70

Other funds holding ANAB

Baker Bros. Advisors's ANAB Position: Q4 2023 in Review

Baker Bros. Advisors sold out of AnaptysBio (ANAB) in Q4 2023, closing a stake of 106,197 shares — an estimated $1.91M sold.

Baker Bros. Advisors first reported a position in ANAB in Q1 2017 and held it in 27 quarters. The position peaked at $24M in Q4 2022. 119 funds tracked by Wall St. Rank hold ANAB as of Q4 2023.

  • Baker Bros. Advisors reported no remaining AnaptysBio position as of Q4 2023 after selling out during the quarter.
  • Baker Bros. Advisors sold 106,197 AnaptysBio shares in Q4 2023, an estimated $1.91M.
  • Baker Bros. Advisors first reported a position in AnaptysBio in Q1 2017 and held it in 27 quarters.
  • Baker Bros. Advisors's AnaptysBio position peaked at $24M in Q4 2022.
  • 119 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2023.

Based on Baker Bros. Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.